Panagora Asset Management Inc Durect Corp Transaction History

Panagora Asset Management Inc

$21 Billion
Q4 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$1.21 - $1.61 $3,231 - $4,300	-2,671 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$1.6 - $2.02 $4,273 - $5,395	2,671 New	2,671 $4,000
Q4 2020 Feb 10, 2021	SELL	$1.65 - $2.43 $43,561 - $64,154	-26,401 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$1.6 - $2.35 $844,568 - $1.24 Million	-527,855 Reduced 95.24%	26,401 $45,000
Q2 2020 Aug 12, 2020	BUY	$1.33 - $2.76 $283,545 - $588,409	213,192 Added 62.51%	554,256 $1.29 Million
Q1 2020 May 14, 2020	SELL	$0.97 - $2.85 $333,701 - $980,462	-344,022 Reduced 50.22%	341,064 $529,000
Q4 2019 Feb 12, 2020	BUY	$1.69 - $3.8 $182,623 - $410,631	108,061 Added 18.73%	685,086 $2.6 Million
Q3 2019 Nov 12, 2019	SELL	$0.61 - $2.21 $115 - $419	-190 Reduced 0.03%	577,025 $1.06 Million
Q2 2019 Aug 09, 2019	SELL	$0.51 - $0.86 $781,109 - $1.32 Million	-1,531,587 Reduced 72.63%	577,215 $376,000
Q1 2019 May 15, 2019	BUY	$0.51 - $0.82 $119,617 - $192,326	234,544 Added 12.51%	2,108,802 $1.32 Million
Q4 2018 Feb 14, 2019	SELL	$0.48 - $1.1 $54,504 - $124,906	-113,551 Reduced 5.71%	1,874,258 $905,000
Q3 2018 Nov 13, 2018	BUY	$1.06 - $1.69 $282,841 - $450,946	266,832 Added 15.5%	1,987,809 $2.19 Million
Q2 2018 Aug 14, 2018	BUY	$1.56 - $2.51 $1.53 Million - $2.45 Million	977,723 Added 131.55%	1,720,977 $2.69 Million
Q1 2018 May 15, 2018	BUY	$0.91 - $2.24 $415,305 - $1.02 Million	456,380 Added 159.09%	743,254 $1.59 Million
Q4 2017 Feb 14, 2018	BUY	$0.78 - $2.1 $162,881 - $438,528	208,823 Added 267.55%	286,874 $264,000
Q3 2017 Nov 14, 2017	BUY	$1.55 - $1.82 $120,979 - $142,052	78,051	78,051 $138,000

Others Institutions Holding DRRX

# of Institutions

Shares Held

593K

Call Options Held

Put Options Held

View Full List

About DURECT CORP

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $173M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

More about DRRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account